Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group
Clinical Lymphoma Myeloma and Leukemia · 2026-07 · 26 (7) · e906-e914.e8
DOI: 10.1016/j.clml.2026.04.017 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-07. Verfasst von Muhammad Umair Mushtaq und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; Mikael Rayaan Foundation Global…. Hauptthemen laut MEDLINE: Cyclophosphamide, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iovance Biotherapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS; U.S. Myeloma Innovatio…
- Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS.
- Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS; Mid America Cancer Care, Kansas City, MO.
- Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS; Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL.
- Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
- Mikael Rayaan Foundation Global Research Training Initiative, Kansas City, KS; Division of Hematology and Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL.
Förderung
- Iovance Biotherapeutics
Zitieren
APA
Mushtaq, M. U., Amin, M. K., Kasaeian, A., Patan, S., Rehman, A. U., Zaheer, A., Sayali, F. O., Rukh, S., Ma'koseh, M., Singh, A. K., Hamadani, M., Mcguirk, J. P., & Shahzad, M. (2026). Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group. Clinical Lymphoma Myeloma and Leukemia, 26(7), e906-e914.e8. https://doi.org/10.1016/j.clml.2026.04.017
Vancouver
Mushtaq MU, Amin MK, Kasaeian A, Patan S, Rehman AU, Zaheer A, et al. Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group. Clinical Lymphoma Myeloma and Leukemia. 2026;26(7):e906-e914.e8. doi:10.1016/j.clml.2026.04.017
BibTeX
@article{Mushtaq2026,
author = {Mushtaq, Muhammad Umair and Amin, Muhammad Kashif and Kasaeian, Amir and Patan, Shajadi and Rehman, Aqeeb Ur and Zaheer, Amna and Sayali, Fatma Ozge and Rukh, Shah and Ma'koseh, Mohammad and Singh, Anurag K and Hamadani, Mehdi and Mcguirk, Joseph P and Shahzad, Moazzam},
title = {Outcomes of Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Over 70 Years of Age: A Comparative Analysis by Age Group},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
volume = {26},
number = {7},
pages = {e906--e914.e8},
doi = {10.1016/j.clml.2026.04.017}
}
EUVIMED